文献速递妇科

巴氏涂片在宫颈癌诊断中的作用:帮助还是阻碍?

Pap tests in the diagnosis of cervical cancer: Help or hinder?
PubMed 文献 · Gynecol Oncol · 2018-01-01

该研究基于加拿大安大略省人群的回顾性队列,纳入2011至2014年确诊的2002例宫颈癌患者,其中75%在确诊前0-2年内做过巴氏涂片;已知细胞学结果者中13%正常、8%低级别、7.5%疑似癌;低级别细胞学导致诊断延迟最长,晚期和腺癌与低级别细胞学风险升高相关。

要点

  • 75%的宫颈癌患者在确诊前0-2年内做过巴氏涂片,其中13%细胞学正常
  • 低级别细胞学结果导致诊断延迟最长(p<0.001)
  • 除FIGO 1A期外,妇产科医生诊断时间显著短于家庭医生

核心结论

  • 作者认为,宫颈癌确诊前0-2年内巴氏涂片检查频繁,可导致假阴性细胞学和晚期癌症患者的诊断延迟。

研究设计与样本

  • 基于人群的回顾性队列研究,纳入加拿大安大略省2011至2014年确诊、年龄≥21岁的宫颈癌患者2002例。

主要发现

  • 共识别2002例患者,75%在确诊前0-2年内做过巴氏涂片;1250例有已知细胞学结果,其中13%正常、8%低级别、7.5%疑似癌。
  • 各FIGO分期中,5-10%细胞学为低级别、3-11.5%为癌阳性、4-41%为正常,正常比例随分期进展而升高。
  • 除FIGO 1A期外,各细胞学结果和FIGO分期下妇产科医生诊断时间均显著短于家庭医生。
  • 低级别细胞学的相关因素包括晚期(OR 4.5(2.4-8.0),p<0.01)和腺癌(OR 1.5(1.1-2.1),p<0.01)。
  • 低级别细胞学导致诊断延迟最长(p<0.001)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of pap tests on the time to diagnosis of cervical cancer. METHODS: In this population-based retrospective cohort study, Ontario women ≥21 years diagnosed with cervical cancer between 2011 and 2014 were identified and database data collected. The presence or absence of a pap test 0-2 years preceding cancer diagnosis was identified. Descriptive and modelling analyses were performed to determine the effect of pap results on cancer diagnosis. RESULTS: 2002 patients were identified, 75% received a pap test. 1250 patients had known cytology - 13% normal, 8% low-grade and 7.5% suspicious for cancer. Across all FIGO stages at diagnosis, 5-10% of cytology was low grade, 3-11.5% was positive for carcinoma and 4-41% was normal, which increased with advancing stage. For all cytology and FIGO stages (except stage 1A), OBGYNs had a significantly shorter time to diagnosis compared to family physicians. Factors increasing the odds of low-grade cytology were advanced stage (OR 4.5 (2.4-8.0), p < 0.01) and adenocarcinoma (OR 1.5 (1.1-2.1), p < 0.01). Low grade cytology resulted in the longest delay to diagnosis (p < 0.001). CONCLUSION: Pap tests are performed frequently in the 0-2 years prior to the diagnosis of cervical cancer which can result in false negative cytology and diagnostic delay in patients with advanced cancers.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Philp L, Jembere N, Wang L, et al. Pap tests in the diagnosis of cervical cancer: Help or hinder? Gynecol Oncol. 2018. PMID: 29773301. doi:10.1016/j.ygyno.2018.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。